Patient characteristics
| Characteristic . | . |
|---|---|
| Median age, y (range) | 62 (32-81) |
| Sex, no. (%) | |
| Female | 55 (37) |
| Male | 95 (63) |
| Rai stage (n = 142), no. (%) | |
| 0-II | 99 (70) |
| III-IV | 43 (30) |
| Binet stage (n = 141), no. (%) | |
| A | 63 (45) |
| B | 41 (29) |
| C | 37 (26) |
| Median β2M serum level, nM (range) (mg/L [range]) | 254 (118-1303); (3 [1.4-15.4]) |
| Previously treated, no. (%) | 58 (39) |
| Characteristic . | . |
|---|---|
| Median age, y (range) | 62 (32-81) |
| Sex, no. (%) | |
| Female | 55 (37) |
| Male | 95 (63) |
| Rai stage (n = 142), no. (%) | |
| 0-II | 99 (70) |
| III-IV | 43 (30) |
| Binet stage (n = 141), no. (%) | |
| A | 63 (45) |
| B | 41 (29) |
| C | 37 (26) |
| Median β2M serum level, nM (range) (mg/L [range]) | 254 (118-1303); (3 [1.4-15.4]) |
| Previously treated, no. (%) | 58 (39) |